ClinicalTrials.Veeva

Menu

Effect of Probiotics on the Periodontal Status of Orthodontic Patients (POP)

U

University Hospital, Lille

Status

Enrolling

Conditions

Periodontal Health
Gingivitis

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Oral probiotics (L. reuteri)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04634201
2019_14
2020-A02179-30 (Other Identifier)

Details and patient eligibility

About

Gingival inflammation (gingivitis) is commonly reported in teenagers with fixed orthodontic devices (FOD). Indeed, FODs promote the accumulation of plaque and interfere with the efficacy of tooth brushing. According to in vitro and in vivo studies, the administration of oral probiotic bacteria including Lactobacillus reuteri may reduce the number of periodontal pathogens in saliva and dental plaque. A recent systematic review shows a positive effect of probiotics in addition to tooth brushing in the treatment of periodontitis. However, there is insufficient data regarding the effect of probiotics in the prevention of gum diseases. The aim of this double-blind randomized placebo-controlled study is to assess the effect of probiotics, in addition to dental brushing, on gum inflammation and the composition of the oral microbiota in teenagers with fixed orthodontic appliances

Enrollment

116 estimated patients

Sex

All

Ages

12 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adolescents aged 12 to 16 benefiting from social security coverage
  • in good general health in brushing and taking treatments
  • Have FODs
  • who consent to the study and whose parents have given their consent
  • suitable for orthodontic treatment in view of his oral state

Exclusion criteria

  • inability to obtain informed consent
  • use of another probiotic or toothpaste / antiseptic mouthwash ≤ 1 month before inclusion
  • allergy or hypersensibiliity to the active substance or to any of the excipients listed in the Gum® PerioBalance® user guide)
  • no history of antibiotic therapy, antiseptic mouthwash ≤ 1 month before inclusion
  • medical contraindication (immunosuppression, pathology requiring prophylactic antibiotic therapy before dental care)
  • physiological, pathological condition, medication or behavior that may have repercussions on the oral cavity (eg: pregnancy, diabetes, antiepileptics, tobacco)
  • oral state requiring other priority care (untreated cavities, untreated active periodontitis, progressive recession)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

116 participants in 2 patient groups

Experimental group
Experimental group
Treatment:
Dietary Supplement: Oral probiotics (L. reuteri)
control group
Sham Comparator group
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Kevimy AGOSSA, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems